| Enzymatic dissociation induces transcriptional and proteotype bias in brain cell populations D Mattei, A Ivanov, M van Oostrum, S Pantelyushin, J Richetto, F Mueller, ... International journal of molecular sciences 21 (21), 7944, 2020 | 99 | 2020 |
| Delivery of antibodies into the murine brain via convection-enhanced delivery M Beffinger, L Schellhammer, S Pantelyushin, J Vom Berg JoVE (Journal of Visualized Experiments), e59675, 2019 | 8 | 2019 |
| Early reduction of SARS-CoV-2-replication in bronchial epithelium by kinin B2 receptor antagonism CA Jakwerth, M Feuerherd, FM Guerth, M Oelsner, L Schellhammer, ... Journal of Molecular Medicine, 1-15, 2022 | 6 | 2022 |
| Exit pathways of therapeutic antibodies from the brain and retention strategies L Schellhammer, M Beffinger, U Salazar, JD Laman, T Buch, J Vom Berg Iscience, 2023 | | 2023 |
| Fc-modified biologicals for local delivery to compartments, in particular to the cns J Vom Berg, D Morger, L Schellhammer, M Beffinger, T Buch US Patent App. 17/599,856, 2022 | | 2022 |
| Fc-MODIFIED BIOLOGICALS FOR LOCAL DELIVERY TO COMPARTMENT, IN PARTICULAR TO THE CNS J Vom Berg, D Morger, L Schellhammer, M Beffinger, T Buch US Patent App. 17/599,921, 2022 | | 2022 |
| Development of a compartment locked IL-12 version with increased tissue retention and minimal peripheral exposure for local glioblastoma therapy L Schellhammer, M Beffinger, S Deplazes, T Shekarian, I Zimmermann, ... Brain Tumor Research and Treatment 10 (Suppl), 2022 | | 2022 |
| DDRE-48. COMPARTMENT LOCKED IL-12-INCREASED TISSUE RETENTION AND MINIMAL PERIPHERAL EXPOSURE ALLOW HIGHER TREATMENT EFFICACY AND TOLERABILITY IN LOCAL GLIOBLASTOMA THERAPY M Beffinger, L Schellhammer, T Shekarian, S Deplazes, I Zimmermann, ... Neuro-Oncology 23 (Supplement_6), vi85-vi85, 2021 | | 2021 |
| Early Reduction of SARS-CoV-2 Replication in Bronchial Epithelium by Kinin B2 Receptor Antagonism (preprint) C Jakwerth, M Feuerherd, F Guerth, M Oelsner, L Schellhammer, ... | | 2021 |
| P09. 10 Local immunotherapy of brain cancer harnessing high-retention Fc-fusion constructs L Schellhammer, M Beffinger, S Pantelyushin, T Buch, J vom Berg Journal for ImmunoTherapy of Cancer 8 (Suppl 2), 2020 | | 2020 |
| SCIDOT-06. TOWARDS EXCLUSIVELY LOCAL THERAPY OF GLIOBLASTOMA-ENGINEERING IL-12Fc WITH SUPERIOR TISSUE RETENTION AND MINIMAL SYSTEMIC EXPOSURE AFTER CNS ADMINISTRATION M Beffinger, L Schellhammer, S Pantelyushin, I Zimmermann, P Egloff, ... Neuro-Oncology 21 (Suppl 6), vi273, 2019 | | 2019 |
| Towards exclusively local therapy of glioblastoma-Engineering IL-12Fc with superior tissue retention and minimal systemic exposure after CNS administration L Schellhammer, M Beffinger, S Pantelyushin, I Zimmermann, P Egloff, ... EUROPEAN JOURNAL OF IMMUNOLOGY 49, 228-229, 2019 | | 2019 |
| SCDT-41. IN VIVO TESTING OF INTRACRANIAL DELIVERY OF RECOMBINANT HUMAN IL-12 AND IL-12Fc AND FUNCTIONAL ASSESSMENT ON HUMAN, PORCINE AND CANINE PERIPHERAL BLOOD MONONUCLEAR CELLS M Beffinger, L Schellhammer, S Pantelyushin, SK Wall, A Bienemann, ... Neuro-Oncology 19 (Suppl 6), vi273, 2017 | | 2017 |
| P06. 09 In vitro assessment of human IL-12Fc function on porcine and canine peripheral blood mononuclear cells L Schellhammer, M Beffinger, A Parshenkov, B Becher, A Bienemann, ... Neuro-Oncology 19 (Suppl 3), iii51, 2017 | | 2017 |
